156 related articles for article (PubMed ID: 23868976)
1. Promoter occupancy of MLL1 histone methyltransferase seems to specify the proliferative and apoptotic functions of E2F1 in a tumour microenvironment.
Swarnalatha M; Singh AK; Kumar V
J Cell Sci; 2013 Oct; 126(Pt 20):4636-46. PubMed ID: 23868976
[TBL] [Abstract][Full Text] [Related]
2. E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases.
Tyagi S; Herr W
EMBO J; 2009 Oct; 28(20):3185-95. PubMed ID: 19763085
[TBL] [Abstract][Full Text] [Related]
3. Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.
Huo H; Magro PG; Pietsch EC; Patel BB; Scotto KW
Cancer Res; 2010 Nov; 70(21):8726-35. PubMed ID: 20861184
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein regulates the mEZH2 promoter via the E2F1-binding site in AML12 cells.
Shi XY; Zhang YY; Zhou XW; Lu JS; Guo ZK; Huang PT
Chin J Cancer; 2011 Apr; 30(4):273-9. PubMed ID: 21439249
[TBL] [Abstract][Full Text] [Related]
5. Lysine methylation regulates E2F1-induced cell death.
Kontaki H; Talianidis I
Mol Cell; 2010 Jul; 39(1):152-60. PubMed ID: 20603083
[TBL] [Abstract][Full Text] [Related]
6. Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia.
Cao F; Townsend EC; Karatas H; Xu J; Li L; Lee S; Liu L; Chen Y; Ouillette P; Zhu J; Hess JL; Atadja P; Lei M; Qin ZS; Malek S; Wang S; Dou Y
Mol Cell; 2014 Jan; 53(2):247-61. PubMed ID: 24389101
[TBL] [Abstract][Full Text] [Related]
7. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.
Tyagi S; Chabes AL; Wysocka J; Herr W
Mol Cell; 2007 Jul; 27(1):107-19. PubMed ID: 17612494
[TBL] [Abstract][Full Text] [Related]
8. G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation.
Rao VK; Ow JR; Shankar SR; Bharathy N; Manikandan J; Wang Y; Taneja R
Nucleic Acids Res; 2016 Sep; 44(17):8129-43. PubMed ID: 27229136
[TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated regulation of E2F1 in DNA damage-induced cell death.
Xie Q; Bai Y; Wu J; Sun Y; Wang Y; Zhang Y; Mei P; Yuan Z
J Recept Signal Transduct Res; 2011 Apr; 31(2):139-46. PubMed ID: 21320024
[TBL] [Abstract][Full Text] [Related]
10. The STAT4/MLL1 Epigenetic Axis Regulates the Antimicrobial Functions of Murine Macrophages.
Carson WF; Cavassani KA; Soares EM; Hirai S; Kittan NA; Schaller MA; Scola MM; Joshi A; Matsukawa A; Aronoff DM; Johnson CN; Dou Y; Gallagher KA; Kunkel SL
J Immunol; 2017 Sep; 199(5):1865-1874. PubMed ID: 28733487
[TBL] [Abstract][Full Text] [Related]
11. MLL1 is essential for the senescence-associated secretory phenotype.
Capell BC; Drake AM; Zhu J; Shah PP; Dou Z; Dorsey J; Simola DF; Donahue G; Sammons M; Rai TS; Natale C; Ridky TW; Adams PD; Berger SL
Genes Dev; 2016 Feb; 30(3):321-36. PubMed ID: 26833731
[TBL] [Abstract][Full Text] [Related]
12. The many facets of MLL1 regulation.
Zhang P; Bergamin E; Couture JF
Biopolymers; 2013 Feb; 99(2):136-45. PubMed ID: 23175388
[TBL] [Abstract][Full Text] [Related]
13. The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage.
Cassimere EK; Pyndiah S; Sakamuro D
Cell Death Differ; 2009 Dec; 16(12):1641-53. PubMed ID: 19629135
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
15. Somatic cancer mutations in the MLL1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR5/RBBP5/ASH2L complex.
Weirich S; Kudithipudi S; Jeltsch A
Mol Oncol; 2017 Apr; 11(4):373-387. PubMed ID: 28182322
[TBL] [Abstract][Full Text] [Related]
16. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
Gu Y; Wang X; Liu H; Li G; Yu W; Ma Q
Oncol Rep; 2018 Oct; 40(4):1863-1874. PubMed ID: 30106440
[TBL] [Abstract][Full Text] [Related]
17. miR-193a targets MLL1 mRNA and drastically decreases MLL1 protein production: Ectopic expression of the miRNA aberrantly lowers H3K4me3 content of the chromatin and hampers cell proliferation and viability.
Sengupta D; Deb M; Kar S; Parbin S; Pradhan N; Patra SK
Gene; 2019 Jul; 705():22-35. PubMed ID: 31005612
[TBL] [Abstract][Full Text] [Related]
18. DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residues.
Glorian V; Allègre J; Berthelet J; Dumetier B; Boutanquoi PM; Droin N; Kayaci C; Cartier J; Gemble S; Marcion G; Gonzalez D; Boidot R; Garrido C; Michaud O; Solary E; Dubrez L
Cell Death Dis; 2017 May; 8(5):e2816. PubMed ID: 28542143
[TBL] [Abstract][Full Text] [Related]
19. The histone methyltransferase activity of MLL1 is dispensable for hematopoiesis and leukemogenesis.
Mishra BP; Zaffuto KM; Artinger EL; Org T; Mikkola HK; Cheng C; Djabali M; Ernst P
Cell Rep; 2014 May; 7(4):1239-47. PubMed ID: 24813891
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
Kim YJ; Jung JK; Lee SY; Jang KL
Cancer Lett; 2010 Feb; 288(2):226-35. PubMed ID: 19656618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
